Mark Donald Chappell

Person

Noblesville, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2...
- Patent number 9,056,844
- Issue date Jun 16, 2015
- Eli Lilly and Company
- Bruce Anthony Dressman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glucagon receptor antagonists, preparation and therapeutic uses
- Patent number 8,084,489
- Issue date Dec 27, 2011
- Eli Lilly and Company
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glucagon receptor antagonists, preparation and therapeutic uses
- Patent number 8,076,374
- Issue date Dec 13, 2011
- Eli Lilly and Company
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glucagon receptor antagonists, preparation and therapeutic uses
- Patent number 7,989,457
- Issue date Aug 2, 2011
- Eli Lilly and Company
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Opioid receptor antagonists
- Patent number 7,902,372
- Issue date Mar 8, 2011
- Eli Lilly and Company
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted thiophene carboxylic amide glucagon receptor antagonist...
- Patent number 7,807,702
- Issue date Oct 5, 2010
- Eli Lilly and Company
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of epothilones, intermediates thereto and analogues thereof
- Patent number 6,867,305
- Issue date Mar 15, 2005
- Sloan-Kettering Institute for Cancer Research
- Samuel J. Danishefsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CGRP ANTIGONISTS USEFUL AS TRACER COMPOUNDS FOR POSITRON EMISSION T...
- Publication number 20230096051
- Publication date Mar 30, 2023
- Eli Lilly and Company
- Mark Donald CHAPPELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2...
- Publication number 20130237573
- Publication date Sep 12, 2013
- Eli Lilly and Company
- Bruce Anthony Dressman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Opioid Receptor Antagonists
- Publication number 20110105571
- Publication date May 5, 2011
- Eli Lilly and Company
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
- Publication number 20100137417
- Publication date Jun 3, 2010
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
- Publication number 20080319074
- Publication date Dec 25, 2008
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
- Publication number 20080300289
- Publication date Dec 4, 2008
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS
- Publication number 20080269296
- Publication date Oct 30, 2008
- Maria-Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS
- Publication number 20080255152
- Publication date Oct 16, 2008
- Maria-Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPIOID RECEPTOR ANTAGONISTS
- Publication number 20080207701
- Publication date Aug 28, 2008
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
- Publication number 20080125468
- Publication date May 29, 2008
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPIOID RECEPTOR ANTAGONISTS
- Publication number 20070066658
- Publication date Mar 22, 2007
- Eli Lilly and Company
- Mark Donald Chappell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diaryl ethers as opioid receptor antagonist
- Publication number 20060217372
- Publication date Sep 28, 2006
- Maria-Jesus Blanco-Pillado
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Synthesis of epothilones, intermediates thereto and analogues thereof
- Publication number 20030176368
- Publication date Sep 18, 2003
- Samuel J. Danishefsky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Synthesis of epothilones, intermediates thereto and analogues thereof
- Publication number 20020058817
- Publication date May 16, 2002
- Samuel J. Danishefsky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Synthesis of epothilones, intermediates thereto and analogues thereof
- Publication number 20020058286
- Publication date May 16, 2002
- Samuel J. Danishefsky
- C07 - ORGANIC CHEMISTRY

Mark Donald Chappell

Person

Patents Grantslast 30 patents

4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2...

Glucagon receptor antagonists, preparation and therapeutic uses

Glucagon receptor antagonists, preparation and therapeutic uses

Glucagon receptor antagonists, preparation and therapeutic uses

Opioid receptor antagonists

Substituted thiophene carboxylic amide glucagon receptor antagonist...

Synthesis of epothilones, intermediates thereto and analogues thereof

Patents Applicationslast 30 patents

CGRP ANTIGONISTS USEFUL AS TRACER COMPOUNDS FOR POSITRON EMISSION T...

4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2...

Opioid Receptor Antagonists

Glucagon Receptor Antagonists, Preparation and Therapeutic Uses

Glucagon Receptor Antagonists, Preparation and Therapeutic Uses

Glucagon Receptor Antagonists, Preparation and Therapeutic Uses

DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS

DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS

OPIOID RECEPTOR ANTAGONISTS

Glucagon Receptor Antagonists, Preparation and Therapeutic Uses

OPIOID RECEPTOR ANTAGONISTS

Diaryl ethers as opioid receptor antagonist

Synthesis of epothilones, intermediates thereto and analogues thereof

Synthesis of epothilones, intermediates thereto and analogues thereof

Synthesis of epothilones, intermediates thereto and analogues thereof